Skip to content
  • Facebook
  • Twitter
  • linkedin
Open Access Publisher of Medical and Social Science Journals
Openventio Publishers
  • Home
  • About us
    • Vision/Mission
    • Open Access
    • Editorial Assessment and Peer Review Process
  • Journals
  • Editorial Guidelines
    • For Authors
    • For Editors
    • For Reviewers
    • For Readers
    • For Librarians
  • Submit Manuscript
  • Contact Us
  • More
    • Advertisement
    • Reprints
    • Privacy Policy
    • FAQs

Volume 2, Issue 2

  • 2015, August

    case report

    Skin Hypopigmentation in a Patient with Papillary Carcinoma Thyroid Treated with SorafenibOpen Access

    Athira Raju, Mathews Jose, Arun Philip and Keechilat Pavithran*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-2-110
    PDF863.63 KB 863.63 KB
    Full-Text (HTML)

  • 2015, September

    editorial

    Boosting Response: The Impact of Immune Checkpoint Inhibitors on Radiation Treatment SchedulesOpen Access

    Firas Mourtada and Jennifer Sims-Mourtada*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-2-e002
    PDF323.50 KB 323.50 KB
    Full-Text (HTML)

  • 2015, September

    mini review

    Treatment of Stage I SeminomaOpen Access

    Milan Anjanappa, Cessal Thommachan Kainickal and Francis V. James*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-2-111
    PDF393.77 KB 393.77 KB
    Full-Text (HTML)

  • 2015, December

    brief research report

    Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant ChemotherapyOpen Access

    Kimberly M. Arnold, Nicole J. Flynn and Jennifer Sims-Mourtada*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-2-112
    PDF3.21 MB 3.21 MB
    Full-Text (HTML)

  • 2015, December

    original research

    The Proportion of ALDEFLUOR-Positive Cancer Stem Cells Changes with Cell Culture Density Due to the Expression of Different ALDH IsoformsOpen Access

    Lynn M. Opdenaker, Shirin R. Modarai and Bruce M. Boman* 
    DOI: http://dx.doi.org/10.17140/CSMMOJ-2-113
    PDF1.14 MB 1.14 MB
    Full-Text (HTML)

×

Article in press

NOTE: The DOIs of the In-Press Articles will only function after the final publication of the articles and once they are uploaded to the Current Issues.
×

Current Issue

×

Previous Issue

  • 2020, March

    editorial

    Pathology Hiding in Plain Sight: The NF1 Plasma MembraneOpen Access

    Vincent M. Riccardi*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-e008
    PDF287.00 KB 287.00 KB
    Full-Text (HTML)

  • 2020, May

    opinion

    Cancer DynamicsOpen Access

    Daniel Gandia* and Cecilia Suárez
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-130
    PDF298.99 KB 298.99 KB
    Full-Text (HTML)

  • 2020, September

    review

    Anastasis: Cell Survival MechanismOpen Access

    Abolaji S. Olagunju*, Folashade G. Olorunfemi, John O. Teibo and Abiodun M. Adewolu
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-131
    PDF515.40 KB 515.40 KB
    Full-Text (HTML)
    Abstract [+]

    Equilibrium between cell survival and death is important for normal cell homeostasis and development and also for inhibiting pathologies particularly cancer. Anastasis is a natural cell recovery phenomenon that rescues cells from the brink of death or a mechanism by which cells recuperate from apoptotic lesions and return to its normal active and functioning state. Programmed cell death (apoptosis) was known to be an intrinsically irreversible cascade that commits cells to a rapid destruction. However,
    recent studies have demonstrated the possibility of recovering dying cells even at the late stages. Anastasis uses the usual pro-metastatic and pro-survival factors to inhibit apoptotic progression. Epithelial mesenchymal transition (EMT) activation and its related modulators is not only linked with cellular metastasis and survivability but also widely associated with the stemness of cancer cells.
    Keywords
    Anastasis; Programmed cell death; Cancer; Pro-metastatic factor; Pro-survival factor; Genetic instability; Cell cycle arrest.


    • Home
    • Authors Instructions
    • Submit Manuscript
    • Contact Us
    • Editorial Panel
    • Article in press
    • Current issue
    • Previous issue
    • Archive
    • Archive

    Connect with us



    Editor-in-Chief

    Pradeep Garg, PhD


    Executive Director
    Center for Molecular Imaging and Therapy
    Biomedical Research Foundation of Northwest Louisiana
    1505 Kings Highway
    Shreveport, LA 71103, USA

    Associate Editors

    Jennifer Sims-Mourtada, PhD


    Senior Clinical Scientist
    Center for Translational Cancer Research
    Helen F. Graham Cancer Center
    Christiana Care Health System
    Newark, DE, USA

    Our editorial team


    Advertisement

    About Openventio

    Openventio Publishers is licensed under a Creative Commons Attribution 4.0 International License.
    based on the work at www.openventio.org

    Quick Links
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement
    Find Us

    Suite#B013, Nexus Business Center
    Block-B, Level 2, Road no. 3
    Film Nagar, Hyderabad
    Telangana State, India

    Openventio Publishers
    • Facebook
    • Twitter
    • linkedin
    © 2014 - 2022 Openventio Publishers. All Rights Reserved.
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement